Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Targeted Medical Pharma, Inc. (TRGM)

Income Statement Business | Product | Geographic

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-15Dec-31-14Dec-31-13Dec-31-12Dec-31-11Dec-31-10Oct-31-10Dec-31-09
   10-K10-K10-K10-K10-K10-K/A10-KS-1/A
Revenues   [+]5.37.19.67.38.87.60.012.2
            Revenue growth  -26.0%-25.6%31.0%-17.2%15.6%-37.5% 0.3%
Cost of goods sold   [+]2.12.23.03.22.82.60.04.4
Gross profit  3.24.96.64.16.15.00.07.8
            Gross margin  60.2%68.8%68.7%56.1%68.7%66.3% 63.6%
Selling, general and administrative   [+]5.27.310.210.111.76.3 2.0
Research and development  0.00.20.20.10.20.3 0.0
Other operating expenses  0.1      3.6
EBITDA   [+]-1.9-2.2-3.4-5.7-5.3-1.2 123.2
            EBITDA margin  -36.8%-31.1%-35.9%-78.2%-60.4%-16.4% 1010.2%
Depreciation  0.10.10.10.20.50.3 121.0
EBITA  -2.0-2.3-3.6-5.9-5.8-1.60.02.2
            EBITA margin  -37.8%-32.9%-37.4%-80.7%-65.6%-20.7% 18.0%
Amortization of intangibles  0.20.30.30.2    
EBIT   [+]-2.2-2.6-3.8-6.1-5.8-1.60.02.2
            EBIT margin  -41.2%-36.7%-40.2%-84.1%-65.6%-20.7% 18.0%
Non-recurring items  -0.1       
Interest expense, net   [+]  0.02.20.00.0  
Other income (expense), net   [+]-1.0-1.20.2-4.4-0.90.70.00.0
Pre-tax income  -3.1-3.8-3.7-12.8-6.6-0.80.02.2
Income taxes  0.00.15.7-3.2-2.5-0.30.0-1.8
            Tax rate  0.8%  24.9%37.2%39.6%  
Minority interest  0.0       
Net income  -3.0-3.9-9.3-9.6-4.2-0.50.04.0
            Net margin  -57.9%-54.8%-97.7%-131.4%-47.4%-6.6% 32.6%
   
Basic EPS   [+]($0.11)($0.15)($0.39)($0.43)($0.19)($0.03)$0.00$0.21
Diluted EPS   [+]($0.11)($0.15)($0.39)($0.43)($0.19)($0.03)$0.00$0.21
   
Shares outstanding (basic)   [+]27.226.423.822.221.918.35.018.6
Shares outstanding (diluted)   [+]27.226.423.822.221.918.55.018.6
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy